These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23361497)

  • 1. Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors.
    Centonze D; Pulvirenti E; Pulvirenti D'Urso A; Franco S; Cinardi N; Giannone G
    Tech Coloproctol; 2013 Oct; 17(5):571-4. PubMed ID: 23361497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach.
    Agaimy A; Vassos N; Märkl B; Meidenbauer N; Köhler J; Spatz J; Hohenberger W; Haller F; Croner RS; Schneider-Stock R; Matzel K
    Int J Colorectal Dis; 2013 Aug; 28(8):1057-64. PubMed ID: 23404343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant imatinib in a gastrointestinal stromal tumor of the rectum: report of a case.
    Ebihara Y; Okushiba S; Kawarada Y; Kitashiro S; Katoh H; Kondo S
    Surg Today; 2008; 38(2):174-7. PubMed ID: 18239881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery.
    Joensuu H; Martin-Broto J; Nishida T; Reichardt P; Schöffski P; Maki RG
    Eur J Cancer; 2015 Aug; 51(12):1611-7. PubMed ID: 26022432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal stromal tumour of the rectum: report of a case and review of literature.
    Grassi N; Cipolla C; Torcivia A; Mandala S; Graceffa G; Bottino A; Latteri F
    World J Gastroenterol; 2008 Feb; 14(8):1302-4. PubMed ID: 18300363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of multiple metastatic giant rectal GIST successfully treated with surgical intervention after administration of imatinib mesylate].
    Kitamura D; Ikeda K; Unotoro J; Seki E; Gonda H; Izumi H
    Nihon Shokakibyo Gakkai Zasshi; 2013 Jan; 110(1):74-80. PubMed ID: 23303232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which is the best surgical approach for anorectal gastrointestinal stromal tumors in the post-imatinib era?
    Pucciarelli S; Maretto I
    Tech Coloproctol; 2013 Oct; 17(5):477-8. PubMed ID: 23624793
    [No Abstract]   [Full Text] [Related]  

  • 8. Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case.
    Nakamura T; Mitomi H; Onozato W; Sato T; Ikeda A; Naito M; Ogura N; Kamata H; Ooki A; Watanabe M
    Surg Today; 2012 Nov; 42(11):1096-9. PubMed ID: 22294424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological analysis of 61 patients with rectal gastrointestinal stromal tumors].
    Wu X; Jiang W; Zhang R; Ding P; Chen G; Lu Z; Li L; Fang Y; Wang F; Kong L; Lin J; Pan Z; Wan D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):335-9. PubMed ID: 24760640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
    Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P
    Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Curative resection for bulky rectal gastrointestinal stromal tumor after neoadjuvant imatinib mesylate].
    Kobayashi H; Uetake H; Higuchi T; Enomoto M; Yasuno M; Iida S; Yoshimura T; Ishikawa T; Ishiguro M; Kato S; Ono H; Kikuchi A; Yamauchi S; Sugihara K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2620-2. PubMed ID: 21224658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategy of rectal gastrointestinal stromal tumor (GIST).
    Liu H; Yan Z; Liao G; Yin H
    J Surg Oncol; 2014 Jun; 109(7):708-13. PubMed ID: 24510506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
    Joensuu H; Eriksson M; Hall KS; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Ballman KV; Leinonen M; DeMatteo RP; Reichardt P
    Cancer; 2014 Aug; 120(15):2325-33. PubMed ID: 24737415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
    Joensuu H; Eriksson M; Sundby Hall K; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Monge OR; Bono P; Kallio R; Vehtari A; Leinonen M; Alvegård T; Reichardt P
    JAMA; 2012 Mar; 307(12):1265-72. PubMed ID: 22453568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum.
    Fujimoto Y; Akiyoshi T; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    Int J Colorectal Dis; 2014 Jan; 29(1):111-6. PubMed ID: 24018650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
    Li J; Dang YZ; Gao J; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):216-20. PubMed ID: 23536338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of adjuvant imatinib therapy in improving the prognosis of patients with colorectal gastrointestinal stromal tumours.
    Li Y; Meng X
    Ann R Coll Surg Engl; 2015 Apr; 97(3):215-20. PubMed ID: 26263807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumors.
    Rutkowski P; Gronchi A
    Oncologist; 2013 Jun; 18(6):689-96. PubMed ID: 23709752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Time is a GIFT in GIST'--the medical and paramedical perspective of a case with metastatic gastrointestinal stromal tumor.
    Sevinc A; Camci C
    Chemotherapy; 2009; 55(1):11-4. PubMed ID: 18974643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients.
    Kanda T; Nishida T; Wada N; Kobayashi O; Yamamoto M; Sawaki A; Boku N; Koseki M; Doi T; Toh Y; Kakeji Y; Sugiyama T; Komatsu Y; Kikuchi S; Ogoshi K; Katai H; Miyachi K; Hirota S; Ohtsu A
    Int J Clin Oncol; 2013 Feb; 18(1):38-45. PubMed ID: 22105894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.